About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 310 record(s)
Req # A-2023-00027
All briefing materials, including and not limited to briefing notes, information notes, scenario notes, prepared and/or provided to the President in May 2023.Organization: Canadian Nuclear Safety Commission
313 page(s)
August 2023
August 2023
Req # A-2023-00028
A list of action items produced by the CNSC’s Executive Team in May 2023. Include any briefing materials including and not limited to: briefing notes, information notes, scenario notes; anything that the Executive Team has been briefed on in May 2023. Also include meeting minutes or agendas.Organization: Canadian Nuclear Safety Commission
125 page(s)
August 2023
August 2023
Req # A-2023-00041
I would like to request PDFs of the following briefing notes from January to May 2023: Internal Audit, Evaluation and Ethics Division Strategic Plan - For the Fiscal Years 2022-25 (6254290), CNSC signing onto NRCan’s Equal by 30 Campaign with commitments (6439339), Approval to proceed with public consultation on REGDOC-1.2.3, Licence Application Guide: Licence to Prepare Site for a Deep Geological Repository (6848782), Overview of Labour Relations Trends (as of December 20, 2022) (6866688), CNSC 2023-24 Departmental Plan (6880897), Key Messages for Minister Wilkinson: International Harmonization (6915405), Concept Paper – Nuclear Roundtable on key issues impacting nuclear projects in Canada (6916442), International Conference on Effective Nuclear and Radiation Regulatory Systems: Preparing for the Future in a Rapidly Changing Environment (6926392), Meeting with Ontario Minister of Energy Todd Smith (6942724), Meeting with Chiefs of Clearwater River, Buffalo River, and Birch Narrows Dene Nations and CEO of NexGen Energy Ltd (6953268), Meeting with NB Power Board of Directors (6955507), Indigenous Advisory Council for the SMR Action Plan Meeting (6976536), Consultations with the Provinces and Indigenous Communities (Recommendations 6, 7, and 8) (6998139), 1st EQUALITY PLAN of the Nuclear Safety Council - Period 2023-2026 (7026792), Results of the survey on career paths and the place of women at ASN (7026794), Role of Gender Equity and Inclusion: 20 years of progress of the Code of Conduct on Safety and Security of Radioactive Sources (7034389), Meeting #6 – IGC-IG on Gender Equality in Nuclear Regulatory Agencies (7044921), SMR projects/vendor design reviews in Canada (7016750), SaskPower Special Project Service Agreement (7005387).Organization: Canadian Nuclear Safety Commission
165 page(s)
August 2023
August 2023
Req # A-2023-00017
A list of action items produced by the CNSC’s Executive Team in April 2023. Include any briefing materials including and not limited to: briefing notes, information notes, scenario notes; anything that the Executive Team has been briefed on in April 2023. Also include meeting minutes or agendas.Organization: Canadian Nuclear Safety Commission
173 page(s)
July 2023
July 2023
Req # A-2023-00018
All briefing materials, including and not limited to briefing notes, information notes, scenario notes, prepared and/or provided to the President in April 2023.Organization: Canadian Nuclear Safety Commission
386 page(s)
July 2023
July 2023
Req # A-2023-00019
provide copies of the following briefing notes, providing interim disclosure as each is prepared for release: * 6628301 — Meet and Greet with the Executive Team * 6909304 — Approval of Service Agreement – Clean Core Thorium Energy Fuel Preliminary Assessment * 6955507 — Meeting with NB Power Board of Directors * 6958790 — The Role of the President: It’s 2 jobs in one! * 6990161 — Poland’s National Atomic Energy Agency (PAA) * 6996360 — Briefing Note to the President CNSC/OPG/NRC/TVA/GEH Meeting * 6998145 — Funding Support towards small modular nuclear reactors (Recommendations 1, 2, and 5) * 6998164 — Nuclear research and development for small modular nuclear reactors, including waste management (Recommendations 3 and 4) * 7018416 — Canadian Nuclear Safety Commission Readiness for Small Modular Reactors and InnovationOrganization: Canadian Nuclear Safety Commission
73 page(s)
July 2023
July 2023
Req # A-2023-00024
Provide the final acknowledgment from the CNSC that the Class IA nuclear facility known as the Pool Test Reactor at the Chalk River Laboratories has been decommissioned including the final application for licence to decommission the same and the final licensing decision by the Commission.Organization: Canadian Nuclear Safety Commission
170 page(s)
July 2023
July 2023
Req # A-2023-00025
Provide every final Harassment and Violence investigation report completed between April 1, 2021 to March 31, 2023. These reports are prepared in accordance with the Work Place Harassment and Violence Prevention Regulations. They are typically held by Human Resources officials (e.g., OHS, Labour Relations, Values and Ethics) in headquarters and regions. Section 30 (2) of the Work Place Harassment and Violence Prevention Regulations states that: "An investigator’s report must not reveal, directly or indirectly, the identity of persons who are involved in an occurrence or the resolution process for an occurrence under these Regulations." As such, there should be little to no ATIP vetting required as these reports are already anonymized.Organization: Canadian Nuclear Safety Commission
20 page(s)
July 2023
July 2023
Req # A-2022-05111
Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on October 6, 2022, or any prior drafts or versions of those 2022 Guidelines (for example, if a draft version was circulated to Health Canada for comment in September 2022, it would be part of the “draft guidelines” for the purpose of this request). • Emails or other communications from Health Canada commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Emails or other communications from the Board members or Board Chair commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Any training presentations, training manuals, or summaries of the new guidelines prepared for use by the Board Staff, Board, or other governmental departments prepared between July 1, 2022, and October 6, 2022. • Any documents with calculations of how much prices will decrease under the draft guidelines, or under alternative pricing rules, and that were prepared between January 1, 2022, and October 6, 2022 (note the change in date relative to other requests). • Any documents comparing prices or price reductions under the draft guidelines and the old PMPRB Compendium of Guidelines and Procedures. • Any documents, including legal memos, on the compliance of the draft guidelines with legal decisions about the PMPRB, including Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2021 FCA 157, Merck Canada c Canada, 2022 QCCA 240, and Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725. • Any documents which discuss how a medicine’s therapeutic class and comparator products will be established under the draft guidelines. • Any documents showing how the Board Staff arrived at the exact pricing tests discussed in paragraph 33-35 of the draft Guidelines. • Any documents which discuss how Board Staff will assess whether a price is excessive *after* an investigation has been opened. For context, the backgrounder which accompanied the draft guidelines suggested that staff will consider “the totality of the circumstances surrounding the price of the medicine, through the lens of the section 85 factors.Organization: Patented Medicine Prices Review Board Canada
197 page(s)
July 2023
July 2023
Req # A-2023-025211
With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.Organization: Patented Medicine Prices Review Board Canada
18 page(s)
July 2023
July 2023